| Spark Physical Therapy, Pllc | |
|
1428 Grand Ave, Billings, MT 59102-3104 | |
| (989) 860-1543 | |
| Not Available |
| Full Name | Spark Physical Therapy, Pllc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 1428 Grand Ave, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407203128 | NPI | - | NPPES |
| M011006923 | Other | MT | PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 7732 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Spark Physical Therapy, Pllc 1428 Grand Ave, Billings, MT 59102-3104 Ph: () - | Spark Physical Therapy, Pllc 1428 Grand Ave, Billings, MT 59102-3104 Ph: (989) 860-1543 |
News Archive
Idera Pharmaceuticals, Inc. presented data on the evaluation of a Toll-like receptor (TLR) antagonist in a preclinical hyperlipidemia model today at the Keystone Symposia conference "Advances in Molecular Mechanisms of Atherosclerosis" being held in Banff, Alberta, Canada. Idera's proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and present a potentially innovative approach for the treatment of certain autoimmune diseases.
An investigational treatment for Marfan syndrome is as effective as the standard therapy at slowing enlargement of the aorta, the large artery of the heart that delivers blood to the body, new research shows. The findings indicate a second treatment option for Marfan patients, who are at high risk of sudden death from tears in the aorta.
In the good old days, responsible parents talked to their children about dating and sex. But these days, in our ever-changing digital world, that's not enough, says Marilyn Maxwell, M.D., professor of pediatrics and internal medicine at Saint Louis University School of Medicine.
A new study published on the preprint server bioRxiv reports the elucidation of the mechanism of inhibition of SARS-CoV-2 by a non-nucleotide inhibitor called suramin. This is the first such compound to be shown to have such activity and shows promise for use as a repurposed drug against COVID-19.
› Verified 4 days ago
Amanda Newbern Langve, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Jonathan W Griffith, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N Ste 140w, Billings, MT 59101 Phone: 406-237-5050 Fax: 406-238-6599 | |
Michael L Kelsey, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3307 Grand Ave, Suite 203, Billings, MT 59102 Phone: 406-655-9060 Fax: 406-655-9065 | |
Garett Cohl Schild, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Logan Yurt, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4652 David Mark Trl, Billings, MT 59101 Phone: 406-861-5466 | |
Bridget Susan Cannon, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Joseph Bloyder, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2702 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 |